Table 1 Selected study characteristics
Year of publication (journal) | Level of evidence | Mean age of patients (year) | Grafts (number of cases) | Technique | Follow-up (months) | mCMS | |
|---|---|---|---|---|---|---|---|
Defrere et al. [19] | 1994 (CORR) | IV | 32 (18.9–70.8) | FL: 47 | TT, SB | 1 year after surgery | 41 |
Jung et al. [20] | 1997 (Bull Hosp Jt Dis) | IV | 28 (20–38) | BT-AT: 19 | Not described, SB | BT-AT: 15.8 (12–28) | 39 |
Toritsuka et al. [5] | 2004 (Arthroscopy) | IV | 24 (15–51) | HA: 156 | Not described, SB/DB | < 12, 12–24, > 24 (5–50) | 49 |
Iwai et al. [21] | 2005 (AOTS) | III | 24.1 (15–44) | BT-AT + ITB: 43 BT-AT alone: 45 | Not described, SB | > 24 | 46 |
Ahn et al. [6] | 2007 (Arthroscopy) | IV | 29.1 (15–54) | HA: 74 | TT, SB | 20.1 (9–32) | 43 |
Ahn et al. [22] | 2007 (KSSTA) | III | 31 (16–60) | BT-AT: 80 HA: 129 | TT, SB | 21.2 (14–70) | 49 |
Kondo et al. [7] | 2007 (Arthroscopy) | II | 27 (13–62) | HA: 136 | TT, DB | 14 (11–24) | 59 |
Otsubo et al. [23] | 2007 (KSSTA) | IV | 24.1 (15–44) | HA: 65 | TP, DB | 16.5 (5–29) | 43 |
Lee et al. [24] | 2010 (Arthroscopy) | IV | BT-AL: 27.9 (13–60) | BT-AL: 16 | TT, SB | BTB: 38 (17–69) | 46 |
TA: 28.6 (15–60) | TA: 47 | TA: 33 (12–66) | |||||
HA: 29.3 (15–52) | HA: 43 | HA: 27 (15–50) | |||||
Mae et al. [25] | 2010 (Arthroscopy) | IV | 31.2 (15–52) | HA: 25 | OI, DB | 13.9 (10–21) | 39 |
Ahn et al. [26] | 2011 (JBJS) | IV | 31 (15–58) | HA: 37 | TT, DB | > 24 | 39 |
Ahn et al. [27] | 2011 (Arthroscopy) | IV | 32.2 (17–54) | HA: 33 | TT, SB | > 12 | 39 |
Kinugasa et al. [8] | 2011 (Arthroscopy) | II | 30.9 (14–71) | HA (A): 55 | OI, DB | HA (A): 14.3 (11–20) | 56 |
HA (B): 36 | HA (B): 13.1 (8–20) | ||||||
HA (C): 11 | HA (C): 15.5 (12–20) | ||||||
Ohsawa et al. [28] | 2012 (AJSM) | III | AM: 24.9 (15–50) | HA: 99 | TP/OI, DB | 1 year after surgery | 46 |
PL: 24.1 (14–46) | |||||||
Ohsawa et al. [29] | 2012 (Arthroscopy) | IV | 36.8 (15–57) | HA: 19 | TP, selective SB | 1 year after surgery | 39 |
Tanaka et al. [30] | 2012 (KSSTA) | IV | 25.5 ± 8.5 | HA: 41 | TP, TB | 6–22 | 43 |
Kim et al. [31] | 2014 (Knee) | III | RP: 28.9 ± 8.8 | HA (RP): 36 | TT, SB | HA (RP): 27.5 ± 3.1 | 43 |
RS: 32.0 ± 9.4 | HA (RS): 30 | HA (RS): 26.6 ± 2.1 | |||||
Nakamae et al. [32] | 2014 (BJJ) | III | SB: 24.6 ± 11.9 | HA (SB): 61 | Not described, SB/DB/AG | HA (SB): 25.6 (18–72) | 53 |
DB: 24.8 ± 11.0 | HA (DB): 82 | ||||||
AG: 26.6 ± 11.4 | HA (AG): 73 | HA (DB): 24.2 (18–41) | |||||
HA (AG): 23.1 (18–72) | |||||||
Ahn et al. [9] | 2015 (Arthroscopy) | III | PA: 37.2 (19–61) | HA (PA): 88 | TP, DB | HA (PA): 45.0 (25–77) | 52 |
NA: 34.7 (15–57) | HA (NA): 66 | HA (NA): 45.5 (25–87) | |||||
Kondo et al. [17] | 2015 (AJSM) | II | 29 (13–58) | HA (RP): 62 | TT, DB | 14 (11–24) | 56 |
HA (RS): 46 | |||||||
Lu et al. [18] | 2015 (AJSM) | II | 26.3 (18–32) | HA (EF): 28 | TP, DB | HA (EF): 80.6 ± 16.3 | 61 |
HA (BL): 65.2 ± 12.8 | |||||||
HA (BL): 31 | |||||||
Choi et al. [33] | 2017 (Knee) | III | 29.1 (15–54) | HA/ACH (RP): 61 | TT, SB | HA/ACH (RP): 14.8 (10–23) | 46 |
HA/ACH (RS): 30 | HA/ACH (RS): 15.1 (10–25) | ||||||
Kim et al. [10] | 2017 (KSSTA) | III | RP: 30.3 ± 11.6 | QA (RP): 42 | TT, SB | QA (RP): 17.9 ± 6.4 | 43 |
RS: 26.3 ± 8.4 | QA (RS): 33 | QA (RS): 18.2 ± 5.8 | |||||
Kim et al. [11] | 2017 (KSSTA) | III | TA: 30.8 ± 13.3 | TA: 30 | TP/OI, SB | TA: 22.5 | 47 |
HA: 28.9 ± 10.1 | HA: 26 | HA: 22.5 | |||||
Matsushita et al. [12] | 2017 (KSSTA) | IV | PL: 35.1 ± 16.4 | HA (PL): 16 | TP, SB/DB | 1 year after surgery | 43 |
SB: 30.1 ± 10.5 | HA (DB): 37 | ||||||
Nakayama et al. [13] | 2017 (Knee) | III | PR: 26.6 (14–55) | HA (PR): 14 | OI, DB | 1 year after surgery | 39 |
RS: 26.4 (12–59) | HA (RS): 22 | ||||||
Xu et al. [34] | 2017 (Med Sci Monit) | III | HA: 32.8 ± 8.9 | HA: 31 | TP, SB | HA: 28.4 ± 2.1 | 43 |
HY: 33.9 ± 8.4 | HY: 37 | HY: 28.3 ± 2.8 | |||||
Yoo et al. [14] | 2017 (KSSTA) | I | TA: 24 (13–52) | TA: 25 | TP, SB | TA: 34.5 (25.3–59.5) | 58 |
HA: 30 (15–62) | HA: 26 | HA: 32.8 (28.7–50.1) |